Regentis Biomaterials Ltd. (RGNT)
1.98
-0.04
(-1.98%)
USD |
NYAM |
Sep 03, 16:00
1.98
0.00 (0.00%)
After-Hours: 20:00
Regentis Biomaterials Enterprise Value : 52.83M for Sept. 2, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 02, 2026 | 52.83M |
| September 01, 2026 | 53.04M |
| August 31, 2026 | 52.93M |
| August 28, 2026 | 52.73M |
| August 27, 2026 | 53.04M |
| August 26, 2026 | 53.09M |
| August 25, 2026 | 53.19M |
| August 24, 2026 | 53.56M |
| August 21, 2026 | 53.24M |
| August 20, 2026 | 53.04M |
| August 19, 2026 | 53.92M |
| August 18, 2026 | 52.68M |
| August 17, 2026 | 52.93M |
| August 14, 2026 | 52.73M |
| August 13, 2026 | 52.21M |
| August 12, 2026 | 52.42M |
| August 11, 2026 | 51.90M |
| August 10, 2026 | 51.95M |
| August 07, 2026 | 52.16M |
| August 06, 2026 | 52.57M |
| August 05, 2026 | 53.09M |
| August 04, 2026 | 53.04M |
| August 03, 2026 | 52.05M |
| July 31, 2026 | 51.38M |
| July 30, 2026 | 51.69M |
| Date | Value |
|---|---|
| July 29, 2026 | 51.59M |
| July 28, 2026 | 51.59M |
| July 27, 2026 | 53.04M |
| July 24, 2026 | 52.52M |
| July 23, 2026 | 52.47M |
| July 22, 2026 | 52.88M |
| July 21, 2026 | 52.93M |
| July 20, 2026 | 52.73M |
| July 17, 2026 | 54.70M |
| July 16, 2026 | 53.87M |
| July 15, 2026 | 54.95M |
| July 14, 2026 | 55.52M |
| July 13, 2026 | 60.34M |
| July 10, 2026 | 62.00M |
| July 09, 2026 | 61.22M |
| July 08, 2026 | 60.91M |
| July 07, 2026 | 61.22M |
| July 06, 2026 | 62.72M |
| July 02, 2026 | 63.24M |
| July 01, 2026 | 66.04M |
| June 30, 2026 | 60.65M |
| June 29, 2026 | 61.89M |
| June 26, 2026 | 62.57M |
| June 25, 2026 | 63.86M |
| June 24, 2026 | 64.12M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Rosetta Genomics Ltd. | -- |
| MBody AI Ltd. | 20.74M |
| Endonovo Therapeutics, Inc. | 7.194M |
| CollPlant Biotechnologies Ltd. | 2.974M |
| Sisram Medical Ltd. | -- |
Enterprise Value Related Metrics
| Earnings Yield | -134.9% |
| Normalized Earnings Yield | -101.39 |